MK-677 side effects: what the actual research shows

What did @enhancedrob actually say?

The creator ran through a list of MK-677 drawbacks: increased appetite, water retention, potential insulin resistance from long-term use, lethargy, higher blood sugar, slow results compared to steroids, and peripheral symptoms like tingling and joint pain. Credit where it's due, this is a more honest framing than most MK-677 content on TikTok, which tends to skip the downsides entirely.

That said, the video is not purely educational. Sprinkled throughout are product plugs, specifically "Shred XT from Ant's Lab" for water retention and "slim pills from Enhanced Labs" as a glucose disposal agent. These recommendations are embedded inside what presents as objective safety information, and that's worth flagging before we get into the science.

Does the science back this up?

Mostly yes, with some important nuances the video glosses over. MK-677 is an orally active ghrelin mimetic and growth hormone secretagogue. Its side effect profile is reasonably well-documented in clinical literature, and most of what the creator lists does appear in that literature.

The appetite increase is real and mechanistically expected. Ghrelin is the hunger hormone, and MK-677 activates ghrelin receptors. A 2008 study by Svensson et al. in the Journal of Clinical Endocrinology and Metabolism confirmed increased appetite as a consistent finding. Water retention and edema are also documented, appearing in a two-year trial by Nass et al. (2008, Annals of Internal Medicine) in elderly subjects. Insulin sensitivity impairment is the most serious concern and the most supported. A 2001 study by Murphy et al. in the American Journal of Physiology found that MK-677 increased fasting glucose and reduced insulin sensitivity in older adults after extended use. Lethargy, particularly in the morning, is anecdotally widespread and plausible given that MK-677 amplifies GH pulses that occur during sleep, which can leave users groggy.

What did they get wrong (or right)?

The creator says MK-677 "does help burn fat" while also increasing appetite. This is a half-truth that deserves more scrutiny. The fat loss claim is based on MK-677's ability to raise IGF-1 and GH, which can shift body composition over time. But the Nass et al. trial found fat mass reductions were modest and inconsistent, and the appetite increase often offsets any metabolic advantage. Framing it as a fat-loss tool while burying the appetite caveat is misleading in practice.

The product recommendations are a bigger problem. Suggesting a specific supplement to counteract insulin resistance, a serious metabolic concern, without recommending bloodwork or physician oversight is irresponsible. A glucose disposal agent supplement is not a clinical intervention for insulin impairment. That framing should not go unchallenged.

On the other hand, "unlike steroids, MK-677 is going to take months" is accurate and genuinely useful information rarely stated in these videos. MK-677 is not anabolic in the same pharmacological sense, and setting realistic timelines is responsible.

What should you actually know?

MK-677 is not FDA-approved for human use and is currently classified by the FDA as an investigational drug, meaning it cannot be legally marketed as a supplement or prescribed off-label through most channels. This is the context the video never provides.

The insulin sensitivity concern is not hypothetical. The Murphy et al. findings and follow-up data suggest that in people with pre-existing insulin resistance or metabolic syndrome, MK-677 may meaningfully worsen glucose regulation. Anyone considering this compound should have fasting glucose and HbA1c baseline labs before starting and regular monitoring during use. That is not optional safety advice. It is the minimum standard of care.

Tingling and numbness, mentioned briefly at the end, are symptoms of carpal tunnel syndrome, a known GH-related side effect. This deserves more than a passing mention. Elevated GH and IGF-1 can cause soft tissue swelling that compresses the median nerve, and this can become persistent.

• MK-677 activates ghrelin receptors, making appetite increases pharmacologically inevitable, not just possible.
• Water retention typically resolves after discontinuation but can be significant during use.
• Insulin sensitivity changes require lab monitoring, not supplement workarounds.
• Long-term human safety data beyond two years is limited.